Autologous Bone-Marrow-Derived-Mononuclear-Cells-Enriched Fat Transplantation in Breast Augmentation: Evaluation of Clinical Outcomes and Aesthetic Results in a 30-Year-Old Female

Dmitry Bulgin

Erik Vrabic

Enes Hodzic

Abstract

1. Introduction

After numerous experiments since 1893 [1, 2], autologous fat transplantation has become a well-established and frequently applied method of soft tissue augmentation for both cosmetic and reconstructive purposes. Tissue augmentation by fat grafting does have several advantages, and many promising results of autologous fat grafts have been published recently [3–8]. Autologous fat is an excellent and extremely promising soft-tissue filler, given its abundance and ease of harvest [9–13]. Selecting suitable indications and correct surgical techniques, low complication rate, and positive results make autologous fat grafting an ideal method for breast augmentation [14, 15].

Published clinical experience in over 2,000 patients who received autologous fat grafts showed no evidence of increased risk of development, metastasis, or recurrence of breast cancer [16–19]. The most significant drawback to autologous fat grafting remains its largely unpredictable rate of resorption, low rate of graft survival due to partial necrosis, and scattered microcalcifications, followed by dispersed radiolucent oil cysts [20–22]. Numerous in vitro and in vivo studies on fat graft viability have recently been done. According to results of these studies, the use of bone-marrow-derived cells is a novel approach to survival of fat grafts [23–25].

The autologous application of BMMNCs which are not expanded ex vivo has medicolegal advantages for clinical use [26]. BMMNCs as a huge source of bone-marrow-derived mesenchymal stem cells (BMMSCs) [27–31] represent a potential key component in the field of regenerative medicine and tissue engineering [32–34]. BMMSCs are multipotent and secrete many kinds of growth factors to regenerate tissues. During the past decade, numerous studies have provided preclinical and clinical data on the safety and efficacy of BMMSCs, supporting the use of these cells in a wide range of clinical applications such as plastic surgery, cardiac surgery, orthopedic surgery, and oral and maxillofacial surgery [35–40]. BMMNCs stimulated angiogenesis as well as maturation of the newly formed blood vessels in vivo. These mechanisms of actions could be beneficial for the stimulation of angiogenesis in ischemic tissues by BMMNCs administration [41]. According to these characteristics, we suggest that the BMMNCs-enriched lipografts can produce aesthetically acceptable results without the need for repeating treatment sessions, which are necessary with autologous fat transplantation.

2. Materials and Methods

2.1. Patient

The patient is a 30-year-old female who requested bilateral breast augmentation. The patient signed a detailed informed consent form of the procedure and possible complications.

The patient has been carefully monitored with preoperative and serial postoperative ultrasonograms (preoperatively, at day 1; postoperatively, after 2 weeks, 4 weeks, 3 months, 6 months, and 12 months).

2.2. Bone-Marrow-Derived Mononuclear Cells Preparation

Autologous bone marrow from the patient was used as a source for BMMNCs. Under general anesthesia, 70.0 mL of the bone marrow was harvested from posterior iliac crest. BMMNCs were separated according to generic volume reduction protocol by using Cell Separation System SEPAX S-100/a table top centrifuge system (Biosafe Group SA, Eysins, Switzerland). The SEPAX S-100 is a cell processing system that uses a rotating syringe technology that provides both separation through rotation of the syringe chamber (centrifugation) and component transfer through displacement of the syringe piston. The SEPAX S-100 system allows the automated processing of cell components in a functionally closed and sterile environment. The SEPAX S-100 provides centrifugal and axial displacement drive to the chamber on the single-use separation kit, as well as drive to the directional valves. The cell separation process is permanently monitored by an optical sensor, fully automated, and completed within 15 to 20 minutes and required a minimum of (nonspecialized) operator intervention. The generic volume reduction protocol uses a single sedimentation step with centrifugal force of 960 ×g and concentrates the final cell product. After processing of the bone marrow, the final BMMNCs product was suspended in 15 mL autologous plasma. Quantitative assessment of cell population by Sysmex KX-21N cell counter (Sysmex Corp., Kobe, Japan), Trypan Blue exclusion test of cell viability, and in vitro haematoxylin and eosin cytological staining was performed to confirm viability and composition of BMMNCs (Figure 1).

2.3. Purified Fat and BMMNCs Mixture Preparation and Breast Augmentation Procedure

After BMMNCs preparation during the same anesthetic event, the patient was admitted for the next surgical procedures which included tumescent syringe liposuction [42] by the Coleman technique, which is based on manual aspiration [43, 44]. Fat was harvested mainly from the abdomen, thighs, and flanks. The harvested fat was transferred into a rigorously closed system Cytori PureGraft 250/PURE System (Cytori Therapeutics, Inc., San Diego, CA, USA). The PureGraft 250 System is indicated for autologous fat transfers. The PureGraft System allows the user to prepare fat grafts within the sterile field in less than 15 minutes. PureGraft selectively washes the graft, drains the tumescent fluid, and removes free lipid and debris. After processing the obtained purified fat and 15.0 mL of BMMNCs product were mixed in the same closed sytem (PureGraft 250 System). The BMMNCs and purified fat mixture was transferred to 10 mL syringes for injection directly into the breast by using micro droplet injection device Celbrush (Cytori Therapeutics, Inc., San Diego, USA) (Figure 2).

Cytori's Celbrush is a stainless steel device intended for use in the delivery of an autologous fat graft. The thumb-brush design gives the Celbrush a mechanical advantage that minimizes the buildup of pressure and provides superior tactile feedback during tissue dispersion. The 10 mL Celbrush is designed to deliver approximately 0.50 mL of tissue for each full brush of the operator's thumb. Minimally manipulated fat combined with BMMNCs was reimplanted strictly in two planes only: into the retroglandular and prefascial space and into the superficial subcutaneous plane of the upper pole of the breast (bicompartmental grafting) (Figure 3).

Any intraparenchymal placement was carefully avoided. Total grafted fat volume was 185.0 mL per breast. Average operation time was 3.5 h. Postoperative follow-up was uneventful and no complications were observed.

3. Results

The patient was satisfied with the soft and natural-appearing augmentation. The breast mounds were soft with no subcutaneous induration and visible injection scars. Postoperative atrophy of injected fat was minimal and did not change substantially after 12 months (Figure 4).

The patient demonstrated improvement in circumferential breast measurement (BRM) from baseline state, and breast measurements were stable by 3 months after surgery. The BRM 12 months after surgery had increased 5.5 cm from preoperative measurements. Breast ultrasound showed no evidence of cyst formation or microcalcification.

4. Discussion

During the past decade, numerous studies have provided preclinical data on the safety and efficacy of BMMNCs, supporting the use of these cells in future clinical applications. Various clinical outcomes have shown the regenerative capability of BMMNCs in subspecialties of medical fields such as plastic surgery, orthopedic surgery, oral and maxillofacial surgery, and cardiac surgery [35, 39, 40, 45]. These preliminary results suggest that BMMNCs-assisted lipotransfer could be effective and safe for soft tissue augmentation and superior to conventional lipoinjection. BMMNCs are an alternative cell source for obtaining mesenchymal stem cells (MSCs). The idea of using BMMNCs autografts is based on the assumption that MSCs among the mononuclear cells, which are present in only relatively small numbers in bone marrow aspirates, can be easily separated ex vivo from the rest of the harvested cells, concentrated in small volume, and immediately implanted into the patient's injured tissue, where the microenvironment will trigger their replication (i.e., cloning) and differentiation into specialized cells. MSCs produce many angiogenic and antiapoptotic growth factors, and their secretion is significantly enhanced by hypoxia [46]. MSCs enhance blood vessel growth not only by production of paracrine-acting factors but also by promoting the endothelial cells differentiation [47]. All of these mechanisms of actions could be beneficial for the stimulation of angiogenesis in transplanted fat by BMMNCs administration. Although an optimal method of cells-assisted autologous fat grafting for primary breast augmentation should be standardized, further strong-evidence-based studies are necessary to confirm the findings of this approach [48, 49].

Breast ultrasound, an accurate and simple imaging technique, plays an important role in follow-up for temporal changes of fat nodules after autologous fat injection. Furthermore, breast ultrasound may avoid unnecessary biopsies [50].

5. Conclusions

It was observed that autologous fat combined with freshly isolated BMMNCs possessed excellent handling characteristics, with no adverse tissue reaction and infection. BMMNCs appear to be an ideal population of stem cells for practical regenerative medicine, given that they are plentiful, of autologous tissue origin and thus nonimmunogenic, and more easily available because of minimal ethical considerations.

The advantages of this method for clinical use in primary breast augmentation are as follows:

the cells do not need to be expanded in vitro; they preserve their angiogenic potential to form new blood vessels and promote the proper graft survival;
the aspirated fat is used as a living scaffold.

Our clinical outcomes showed that the procedure is safe and effective, providing improvement after a single treatment. Further long-term studies are necessary to confirm the favorable results seen in this study.

Figure 1

Bone-marrow-derived mononuclear cells preparation: (a) the bone marrow harvesting from posterior iliac crest, (b) collection of bone marrow in plastic bag, (c) the bone marrow processing by using Cell Separation System SEPAX S-100, and (d) qualitative assessment of BMMNCs population by haematoxylin and eosin cytological staining (×400).

Figure 2

Purified fat and BMMNCs mixture preparation: (a) the harvested fat after tumescent syringe liposuction, (b) the purified fat in Cytori PureGraft 250/PURE System, and (c) the BMMNCs and purified fat mixture transferring to 10 mL syringe.

Figure 3

Purified fat and BMMNCs mixture reimplantation: (a) and (b) breast augmentation procedure (bicompartmental grafting).

Figure 4

Clinical outcomes and aesthetic results after BMMNCs-enriched lipograft for primary bilateral breast augmentation: preoperative views (top), and postoperative views at 14 days (middle), postoperative views at 12 months (bottom); (A) right view, (B) front view, and (C) left view.

Acknowledgments

The authors would like to thank Dr. Sadanori Akita, Dr. Hiroshi Yoshimoto, and Mr. Robert Sekac for their contribution to the case report.

References

1. NeuberGAVerhandlungen der Deutschen Gesellschaft für Chirurgiep. 66, 1893. (German)
2. CzernyVPlastic replacement of the breast with a lipomaChirurgie Kong Verhandlungen18952p. 216[Google Scholar]
3. HudsonDALambertEVBlochCESite selection for fat autotransplantation: some observationsAesthetic Plastic Surgery1990143195197[PubMed][Google Scholar]
4. SarfatiIIhraiTKaufmanGNosCCloughKBAdipose-tissue grafting to the post-mastectomy irradiated chest wall: preparing the ground for implant reconstructionJournal of Plastic, Reconstructive and Aesthetic Surgery201164911611166[PubMed][Google Scholar]
5. LimAAFanKAllamKAAutologous fat transplantation in the craniofacial patient: the UCLA experienceThe Journal of Craniofacial Surgery201223410611066[PubMed][Google Scholar]
6. ScorzaARScorzaLRTroccolaAMicciDMRausoRCuringaGAutologous fat transfer for face rejuvenation with tumescent technique fat harvesting and saline washing: a report of 215 casesDermatology20122243244250[PubMed][Google Scholar]
7. LoskenAPinellXASikoroKYezhelyevMVAndersonECarlsonGWAutologous fat grafting in secondary breast reconstructionAnnals of Plastic Surgery2011665518522[PubMed][Google Scholar]
8. MizunoHHyakusokuHFat grafting to the breast and adipose-derived stem cells: recent scientific consensus and controversyAesthetic Surgery Journal2010303381387[PubMed][Google Scholar]
9. SmahelJAdipose issue in plastic surgeryAnnals of Plastic Surgery1986165444453[PubMed][Google Scholar]
10. BircollMNovackBHAutologous fat transplantation employing liposuction techniquesAnnals of Plastic Surgery1987184327329[PubMed][Google Scholar]
11. BuckyLPPercecIThe science of autologous fat grafting: views on current and future approaches to neoadipogenesisAesthetic Surgery Journal2008283313321[PubMed][Google Scholar]
12. SterodimasAde FariaJNicarettaBBorianiFAutologous fat transplantation versus adipose-derived stem cell-enriched lipografts: a studyAesthetic Surgery Journal2011316682693[PubMed][Google Scholar]
13. NguyenPSDesouchesCGayAMHautierAMagalonGDevelopment of micro-injection as an innovative autologous fat graft technique: the use of adipose tissue as dermal fillerJournal of Plastic Reconstructive and Aesthetic Surgery2012651216921699[Google Scholar]
14. SommerBSattlerGCurrent concepts of fat graft survival: histology of aspirated adipose tissue and review of the literatureDermatologic Surgery2000261211591166[PubMed][Google Scholar]
15. DelayEGarsonSToussonGSinnaRFat injection to the breast: technique, results, and indications based on 880 procedures over 10 yearsAesthetic Surgery Journal2009295360376[PubMed][Google Scholar]
16. RigottiGMarchiAStringhiniPDetermining the oncological risk of autologous lipoaspirate grafting for post-mastectomy breast reconstructionAesthetic Plastic Surgery2010344475480[PubMed][Google Scholar]
17. FraserJKHedrickMHCohenSRBreast surgery review article: oncologic risks of autologous fat grafting to the breastAesthetic Surgery Journal20113116875[PubMed][Google Scholar]
18. PetitJYBotteriELohsiriwatVLocoregional recurrence risk after lipofilling in breast cancer patientsAnnals of Oncology2012233582588[PubMed][Google Scholar]
19. PetitJYLohsiriwatVCloughKBThe oncologic outcome and immediate surgical complications of lipofilling in breast cancer patients: a multicenter study-milan-paris-lyon experience of 646 lipofilling proceduresPlastic and Reconstructive Surgery20111282341346[PubMed][Google Scholar]
20. CarvajalJPatiñoJHMammographic findings after breast augmentation with autologousAesthetic Surgery Journal2008282153162[PubMed][Google Scholar]
21. PelosiMAPelosiMAIIBreast augmentationObstetrics and Gynecology Clinics of North America2010374533546[PubMed][Google Scholar]
22. WangC-FZhouZYanY-JZhaoD-MChenFQiaoQClinical analyses of clustered microcalcifications after autologous fat injection for breast augmentationPlastic and Reconstructive Surgery2011127416691673[PubMed][Google Scholar]
23. YiCPanYZhenYEnhancement of viability of fat grafts in nude mice by endothelial progenitor cellsDermatologic Surgery2006321214371443[PubMed][Google Scholar]
24. ButalaPHazenASzpalskiCSultanSMColemanSRWarrenSMEndogenous stem cell therapy enhances fat graft survivalPlastic and Reconstructive Surgery20121302293306[PubMed][Google Scholar]
25. HamedSBen-NunOEgoziDTreating fat grafts with human endothelial progenitor cells promotes their vascularization and improves their survival in diabetes mellitusPlastic and Reconstructive Surgery20121304801811[PubMed][Google Scholar]
26. JägerMHernigouPZilkensCHertenMFischerJKrauspeRCell therapy in bone healing disordersOrthopedic Reviews2010227987[Google Scholar]
27. PittengerMFMackayAMBeckSCMultilineage potential of adult human mesenchymal stem cellsScience19992845411143147[PubMed][Google Scholar]
28. AlhadlaqAMaoJJMesenchymal stem cells: isolation and therapeuticsStem Cells and Development2004134436448[PubMed][Google Scholar]
29. Castro-MalaspinaHGayREResnickGCharacterization of human bone marrow fibroblast colony-forming cells (CFU-F) and their progenyBlood1980562289301[PubMed][Google Scholar]
30. ProckopDJMarrow stromal cells as stem cells for nonhematopoietic tissuesScience199727653097174[PubMed][Google Scholar]
31. PittengerMFMesenchymal stem cells from adult bone marrowMethods in Molecular Biology20084492744[PubMed][Google Scholar]
32. KawaguchiHHirachiAHasegawaNEnhancement of periodontal tissue regeneration by transplantation of bone marrow mesenchymal stem cellsJournal of Periodontology200475912811287[PubMed][Google Scholar]
33. RobeyPGBiancoPThe use of adult stem cells in rebuilding the human faceJournal of the American Dental Association20061377961972[PubMed][Google Scholar]
34. JägerMJelinekEMWessKMBone marrow concentrate: a novel strategy for bone defect treatmentCurrent Stem Cell Research and Therapy2009413443[PubMed][Google Scholar]
35. WuYWangJScottPGTredgetEEBone marrow-derived stem cells in wound healing: a reviewWound Repair and Regeneration2007151S18S26[PubMed][Google Scholar]
36. MishraPKBone marrow-derived mesenchymal stem cells for treatment of heart failure: is it all paracrine actions and immunomodulation?Journal of Cardiovascular Medicine200892122128[PubMed][Google Scholar]
37. ChoiSHJungSYKwonSMBaekSHPerspectives on stem cell therapy for cardiac regeneration. Advances and challengesCirculation Journal201276613071312[PubMed][Google Scholar]
38. BulginDHodzicEKomljenovic-BlitvaDAdvanced and prospective technologies for potential use in craniofacial tissues regeneration by stem cells and growth factorsJournal of Craniofacial Surgery2011221342348[PubMed][Google Scholar]
39. BulginDIrhaEHodzicENemecBAutologous bone marrow derived mononuclear cells combined with β-tricalcium phosphate and absorbable atelocollagen for a treatment of aneurysmal bone cyst of the humerus in childJournal Biomaterials Applications2012[Google Scholar]
40. BulginDHodzicEAutologous bone marrow-derived mononuclear cells combined with β-TCP for maxillary bone augmentation in implantation proceduresThe Journal of Craniofacial Surgery201223617283172[PubMed][Google Scholar]
41. Tateishi-YuyamaEMatsubaraHMuroharaTTherapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trialLancet20023609331427435[PubMed][Google Scholar]
42. HunstadJPTumescent and syringe liposculpture: a logical partnershipAesthetic Plastic Surgery1995194321333[PubMed][Google Scholar]
43. ColemanSRStructural fat graftingAesthetic Surgery Journal1998185386388[PubMed][Google Scholar]
44. PuLLQColemanSRCuiXFergusonREHVasconezHCAutologous fat grafts harvested and refined by the coleman technique: a comparative studyPlastic and Reconstructive Surgery20081223932937[PubMed][Google Scholar]
45. de LezoJSHerreraCRomeroMFunctional improvement in patients with dilated cardiomyopathy after the intracoronary infusion of autologous bone marrow mononuclear cellsRevista Espanola de Cardiologia2013666450457[PubMed][Google Scholar]
46. AsaharaTMuroharaTSullivanAIsolation of putative progenitor endothelial cells for angiogenesisScience19972755302964967[PubMed][Google Scholar]
47. WollertKCDrexlerHClinical applications of stem cells for the heartCirculation Research2005962151163[PubMed][Google Scholar]
48. YoshimuraKSatoKAoiNKuritaMHirohiTHariiKCell-assisted lipotransfer for cosmetic breast augmentation: supportive use of adipose-derived stem/stromal cellsAesthetic Plastic Surgery20083214855[PubMed][Google Scholar]
49. RosingJHWongGWongMSSaharDStevensonTRPuLLQAutologous fat grafting for primary breast augmentation: a systematic reviewAesthetic Plastic Surgery2011355882890[PubMed][Google Scholar]
50. WangHJiangYMengHZhuQDaiQQiKSonographic identification of complications of cosmetic augmentation with autologous fat obtained by liposuctionAnnals of Plastic Surgery2010644385389[PubMed][Google Scholar]